|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 89 No. 10 (May 15), 1997:
pp. 3837-3846
Neutrophils Can Adhere Via 4 1 -Integrin Under Flow Conditions
By
Paul H. Reinhardt,
John F. Elliott, and
Paul Kubes
From the Immunology Research Group, University of Calgary, Calgary, Alberta, Canada; and the Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
 |
ABSTRACT |
In this study we investigated the possibility that an alternative pathway exists for neutrophil recruitment, namely an 4 1 -dependent pathway. A parallel plate chamber was used to investigate whether neutrophils could tether, roll, and adhere to tumor necrosis factor (TNF )-stimulated endothelium via 4 1 . 4 1 -integrin was induced on neutrophils using dihydrocytochalasin B and either an endogenous (endothelial-derived) chemotactic agent or an exogenous chemotactic molecule. 4 1 -expressing neutrophils could stably adhere under shear force (2 dyne/cm2) to TNF -stimulated endothelium independent of the 2 -integrin. The firm adhesion was entirely abolished by antibodies directed against either the 4 or 1 -integrin subunits. However, the rolling interaction was not dependent on 4 1 but was abolished by antiselectin therapy. Neutrophils expressing 4 1 could also tether to the endothelium in the presence of antiselectin therapy, but at shear stresses less than 2 dyne/cm2. 4 1 -expressing neutrophils also tethered to and stably adhered (no rolling) to VCAM-1- but not to ICAM-1-transfected L cells. The interaction only occurred at shear stress less than 2 dyne/cm2. A cell line (Ramos) known to express high quantities of 4 1 -integrin interacted with VCAM-1-transfected L cells at very similar shear conditions. 4 1 -expressing neutrophils were also able to adhere to a second 4 -integrin ligand, fibronectin; however, this interaction only occurred under static conditions. These data suggest that, under certain conditions, neutrophils can adhere independently of the 2 -integrin pathway and adhere via the 4 1 -integrin. This study refutes the concept that 4 1 -integrin adhesion is restricted to mononuclear leukocytes and is not functional on human neutrophils.
 |
INTRODUCTION |
INAPPROPRIATE activation or recruitment of neutrophils has been implicated in the pathogenesis of various inflammatory diseases.1 The recruitment process is characterized by a cascade of events, starting with the neutrophil initially tethering to activated endothelium and then rolling along the endothelial surface. The tethering and rolling event is thought to be dependent on a number of adhesion molecules on the surface of neutrophils, including L-selectin2,3 and P-selectin glycoprotein ligand-1 (PSGL-1).4 There is also a requirement for the expression of counterligands on endothelium, including P-selectin, a rapidly mobilized molecule,5-8 and E-selectin, which is expressed after cytokine stimulation.9 The identity and expression profiles of other selectin ligands remain unclear. The rolling velocity of neutrophils is then reduced and the cells come to a complete stop. This firm adhesion is known to be mediated by 2 integrins (CD11/CD18) on the neutrophil surface.10 Although this cascade of events has been proposed for neutrophils as well as other leukocytes, it is becoming clear that non-neutrophilic leukocytes can use a second integrin, 4 1 , to firmly adhere and in some but not all instances to tether and roll.11,12 The importance of this observation is that 4 1 -integrin could conceivably replace the selectin and 2 -integrin pathway and constitute an alternative recruitment pathway.
Based on the fact that neutrophils are generally thought not to express 4 1 -integrin, this pathway should be unimportant in neutrophil recruitment. However, we have recently reported that human neutrophils stimulated with chemotactic factors in the presence of dihydrocytochalasin B (DHCB) to optimize neutrophil effector responses expressed 4 1 -integrin.13 This expression occurred quickly (within 10 minutes), indicating that 4 1 was stored and available for rapid mobilization. Although DHCB was not a physiologic stimulus, transmigration of neutrophils across endothelium also induced the expression of 4 1 -integrin on neutrophils, suggesting, albeit indirectly, that nonpharmacologic stimuli can also induce expression of 4 1 -integrin on the surface of neutrophils. Interestingly, a recent publication reported that circulating rat neutrophils express 4 -integrin and that blockade of 4 -integrin improved the ability of a 2 -integrin antibody to inhibit neutrophil infiltration into arthritic joints.14 Although intriguing, the inhibition of neutrophil infiltration by an antibody that immunoneutralizes 4 -integrin may be related to indirect effects such as inhibition of mononuclear cell infiltration that could affect subsequent neutrophil recruitment.
Therefore, the objective of this study was to determine whether 4 1 -integrin could directly contribute to neutrophil interactions with biologic substrata under shear conditions. To do this, we used a flow chamber apparatus to mimic the shear conditions found in blood vessels and examined whether DHCB-primed neutrophils were able to use 4 1 for rolling and adhesion on tumor necrosis factor (TNF )-stimulated endothelium. Next, we examined whether neutrophils could use 4 1 to interact with VCAM-1-transfected L cells at a variety of shear forces and we examined how these interactions compared with interactions of Ramos cells that are known to express 4 1 .15 Finally, we examined whether 4 1 -expressing neutrophils could interact with another 4 1 -integrin ligand, fibronectin, under both static and shear conditions.
 |
MATERIALS AND METHODS |
Monoclonal antibodies (MoAbs) and reagents.
The MoAb IB4 (anti-CD18) was a gift from Dr Karl E. Arfors (Experimental Medicine Inc, Princeton, NJ). MoAb EL-246 (anti-E/L-selectin) was a gift from Dr Mark Jutila (Montana State University, Bozeman, MT). MoAb HP2/1 (anti- 4 ) was purchased from Serotec (Kidlington, Oxford, UK) and MoAb HP1/2 (anti- 4 ) was a gift from Dr Roy Lobb (Biogen, Cambridge, MA). MoAbs K20 and LIA 1/2 (anti- 1 -integrin antibodies) were purchased from AMAC Inc (Westbrook, ME). TNF was a gift from Knoll Pharmaceutical (Markum, Ontario, Canada). Purified human fibronectin fragment 40K was purchased from Chemicon International Inc (Temecula, CA). Unless otherwise stated, all other reagents were purchased from Sigma Chemical Co (St Louis, MO).
Preparation of substrates.
Human umbilical vein endothelial cells (HUVEC) were harvested from freshly collected umbilical cords. Briefly, umbilical cord veins were rinsed of formed blood products with phosphate-buffered saline (PBS), after which the vein was filled with a collagenase solution (320 U/mL in PBS). After 20 minutes of incubation at 37°C, the cords were gently massaged to ensure detachment of endothelial cells from the vessel wall. The digest was collected into centrifuge tubes and the collagenase was inactivated with fetal calf serum (FCS), after which the tube was centrifuged (400g for 10 minutes at 37°C). The pellet was resuspended in medium 199 containing 10% FCS, endothelial mitogen (Biomedical Technologies, Inc, Stoughton, MA), and antibiotics. The endothelial cells were seeded onto 75-cm2 culture flasks and maintained in 5% CO2 at 37°C and 96% humidity. Occasionally, the identity of endothelial cultures was confirmed by staining with fluorescein isothiocyanate-labeled factor VIII antibody. HUVEC were expanded by trypsinization and used for experimentation before the fifth passage.
The construction of mouse L-cell transfectants was accomplished as follows. cDNAs encoding VCAM-1 and ICAM-1 proteins were generated by polymerase chain reaction and ligated into the plasmid pJFE14 using the Xba I and Not I sites. pMSD4-HPRT, which expresses murine HPRT under the control of a Moloney murine leukemia virus promoter, was a gift from Dr D. Denney (Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada). Mouse LA9 cells (American Type Culture Collection [ATCC], Rockville, MD) that permanently express VCAM-1 or ICAM-1 were constructed by cotransfecting Sal I-cut pJFE14 containing the appropriate cDNA (200 µg/electrophoration) and Sal I-cut pMSD4-HPRT DNA (10 µg/electrophoration). After electrophoration (BioRad Gene Pulser apparatus; BioRad, Mississauga, Ontario, Canada), cells were cultured in selection media (Dulbecco's modified Eagle's medium [DMEM; GIBCO, Grand Island, NY] with 10% fetal calf serum [Hyclone, Logan, UT] and hypoxanthine 100 µmol/L/azaserine 5.8 µmol/L). After 10 to 14 days, single colonies of HPRT+ LA9 cells were picked using cloning cylinders and expanded. Clones were incubated for an additional 6 to 10 days in selection media, after which they were cultured in DMEM containing 10% FCS. VCAM-1 expression on TNF -stimulated HUVEC was 60% of that found on VCAM-1 transfectants as determined by enzyme-linked immunosorbent assay.
Neutrophil isolation, labeling, and treatment.
Human neutrophils were harvested from citrate anticoagulated venous blood collected from healthy donors as previously described,9 with minor modifications. All isolation steps were performed at room temperature. Neutrophils were purified by dextran sedimentation (Dextran 250,000; Spectrum Chemicals, Gardena, CA) followed by centrifugation through a density gradient (6.07% Ficoll Type 400 [Sigma] with 10% Hypaque Sodium [Markham, Ontario, Canada]). Isolated neutrophils were resuspended in Hanks' balanced salt solution (HBSS) at a density of 1 × 106 cells/mL. This yielded neutrophils that were 97% pure and 95% viable.
4 1 -dependent interactions of neutrophils with various substrata were compared directly with those of Ramos cells (ATCC) that use this integrin to tether, roll, and adhere. Ramos cells were cultured in RPMI medium 1640 with 10% FCS. For experimental procedures, Ramos cells were pelleted and resuspended in HBSS at a density of 1 × 106 cells/mL.
For static adhesion assays, neutrophils were radiolabeled by incubating purified neutrophils with Na51CrO4 (30 µCi/mL) at 37°C for 30 minutes. The cells were washed three times and resuspended in HBSS at 2 × 107 cells/mL.
Flow chamber assay.
To study neutrophil behavior under shear conditions, a flow chamber assay was established as previously described.16 HUVEC, VCAM-1 transfectants, or ICAM-1 transfectants were seeded onto glass coverslips (Fisher Scientific, Ottawa, Ontario, Canada) at a density of 1 × 106 cells per coverslip. The cells were allowed to grow to form confluent monolayers. Coverslips were mounted into a polycarbonate chamber with parallel plate geometry. The flow chamber was placed onto the stage of an inverted microscope (Zeiss, Don Mills, Ontario, Canada) and monolayers were visualized at 200× magnification using phase contrast imagery. The stage area was enclosed in a warm air cabinet and maintained at 37°C. Neutrophil or Ramos cell suspensions were warmed to 37°C using a water bath. A syringe pump (Harvard Apparatus, St. Laurent, Quebec, Canada) was used to draw the cell suspensions through the flow chamber at defined wall shear stresses. Experiments were video recorded for later analysis via a CCD camera (Hatachi Denshi, Ltd, San Jose, CA) and a video cassette recorder (Panasonic, Secaucus, NJ) that was attached to the microscope.
4 1 -dependent neutrophil interactions with TNF -stimulated endothelium (300 U/mL) were performed in the presence of DHCB at 2.5 µg/mL. This concentration of DHCB in the presence of an endothelial-derived chemotactic agent (as a result of TNF stimulation) has previously been shown to induce significant 4 1 -integrin expression on neutrophils.13 DHCB was present in the perfusion medium throughout the tethering, rolling, and adhesion assays. Neutrophils were pretreated with DHCB at 2.5 µg/mL for 10 minutes. MoAb IB4 (20 µg/mL) directed against the 2 -integrin was used alone or in combination with anti- 4 MoAbs (HP2/1 [2.0 µg/mL], HP1/2 [2.0 µg/mL]) or anti- 1 -integrin (MoAbs LIA 1/2 [2.0 µg/mL] or K20 [2.0 µg/mL]) to elucidate the adhesive mechanism of DHCB-pretreated neutrophils with TNF -stimulated HUVEC under shear conditions (2 dyne/cm2 ). A role for selectins on 4 1 -expressing neutrophils was determined using an anti-E/L-selectin antibody MoAb EL-246 (50 µg/mL) or the selectin-binding carbohydrate fucoidan (75 µg/mL). In additional experiments, MoAb EL-246 was added and neutrophils were perfused under conditions of decreasing shears (0.5 dyne/cm2 at 2-minute intervals) in the presence and absence of HP2/1. This was performed to establish whether 4 1 could tether neutrophils to endothelium independent of selectins.
To determine whether 4 1 -expressing neutrophils could support interaction with VCAM-1-transfected L cells, neutrophils expressing 4 1 were perfused over either VCAM-1 or ICAM-1 transfectants at a starting shear of 2 dyne/cm2. Because neither Ramos cells nor 4 1 -expressing neutrophils would tether to VCAM-1 transfectants, shear was decreased by 0.5 dyne/cm2 at 2-minute intervals. In this series of experiments, TNF could not be used (as endothelium was not used), so neutrophils were pretreated with an exogenous chemotactic agent FMLP (20 µmol/L) + DHCB (2.5 µg/mL) for 10 minutes, which also expresses 4 1 .13 In additional experiments, Ramos cells were also pretreated with phorbol 12-myristate 13-acetate (PMA; 50 ng/mL for 10 minutes) to increase 4 1 avidity. Detachment assays were performed on 4 1 -expressing neutrophils or Ramos cells by allowing the leukocytes to settle for 2 minutes on VCAM-1 transfectants under static conditions and then re-establishing flow through the chamber to 2 dyne/cm2.
In addition to 4 1 -integrin interacting with VCAM-1, 4 1 also interacts with the CS-1 region of fibronectin.17 In a final series of flow experiments, 4 1 -expressing neutrophils were perfused over fibronectin-treated coverslips (25 µg/mL for 30 minutes) under conditions of decreasing shear. Neither Ramos nor 4 1 -expressing neutrophils interacted with this surface at any shear stress tested; therefore, static adhesion assays were performed.
Static adhesion assay.
Forty-eight-well plates (Costar, Cambridge, MA) were coated with human fibronectin (25 µg/mL in PBS) and radiolabeled neutrophils were added to the wells (1 × 106/well in 500 µL HBSS) and the plate was incubated for 30 minutes at 37°C. At the end of the incubation, the supernatant of each well was collected and the wells were gently washed with 500 µL of HBSS. The cells that remained adherent were lysed by an overnight incubation with 500 µL of NaOH (2 N). Supernatant, wash, and lysate were analyzed for 51Cr activity and the neutrophil adherence was calculated as the ratio of radioactivity in the cell lysate versus that in supernatant, wash, and lysate combined. 4 1 -expressing neutrophils were exposed to fibronectin in the presence of antibody IB4 (20 µg/mL) in combination with a fibronectin fragment (fragment 40K, 0.2 µg/mL) that contains the CS-1 binding region for 4 1 or with antibody HP2/1 (2.0 µg/mL).
Experimental analysis and statistics.
Rolling and adhesive interactions of perfused cells with cell monolayers was determined for each minute of perfusion. Cell counts were made for the field of microscopic view and represented as cells per millimeter squared of the monolayer surface. A rolling cell was defined as a cell that was in contact with the monolayer but was not stationary. These cells could be observed to roll end over end across the monolayer surface. An adherent cell was defined as one that was in contact with the monolayer and remained stationary for at least 10 seconds. In experiments in which flow in the chamber was stopped, rolling and adherent leukocyte number was determined for the first minute of flow reperfusion. All experiments were repeated between 3 and 8 times. All values are expressed as mean ± SEM, and means were compared by a Student's t-test with Bonferroni correction for multiple comparisons. Statistical significance was set at P < .05.
 |
RESULTS |
Unstimulated neutrophils interact with cytokine-stimulated endothelium under shear conditions via selectins and 2 -integrins.
Freshly isolated neutrophils were observed to tether and roll on TNF -stimulated endothelium (HUVEC) at a wall shear stress of 2 dyne/cm2 (Fig 1A). Also, rolling cells were observed to stop and firmly adhere to the endothelium (Fig 1B). Tethering, rolling, and adhesive interactions increased during the time of perfusion. The addition of an MoAb (EL-246) that inhibits the actions of both E- and L-selectin completely blocked tethering and rolling (Fig 1A), indicating that these interactions are selectin-dependent. Identical results were observed when fucoidan, a selectin-binding polysaccharide, was administered (data not shown). These regimens also completely inhibited neutrophil adhesion, consistent with the view that tethering and rolling are a prerequisite for firm adhesion. The addition of an MoAb (IB4 ) that immunoneutralizes 2 -integrins blocked neutrophil adhesion to TNF -stimulated endothelium (Fig 1B). IB4 did not inhibit this adhesion by affecting the ability of neutrophils to tether and roll on endothelium. In fact, IB4 pretreatment resulted in an increase in the number of rolling cells (data not shown) most likely as a result of the reduced propensity of these cells to adhere.

View larger version (12K):
[in this window]
[in a new window]
| Fig 1.
Neutrophils tether to TNF -treated endothelium, roll (A), and adhere (B). The tethering and rolling was entirely inhibited by an E-selectin/L-selectin antibody (EL-246; A). The anti-CD18 antibody (IB4 ) inhibited neutrophil adhesion (B) without inhibiting rolling (data not shown). ( ) Without antibody; ( ) with antibody. *P < .05 relative to untreated neutrophils.
|
|
4 1 -expressing neutrophils adhere to TNF -stimulated endothelium independent of 2 -integrin.
We have previously shown that neutrophils can be induced to express 4 1 when stimulated with DHCB in combination with an exogenous chemotactic stimulus or in the presence of an endogenous chemotactic stimulus (derived from TNF -stimulated endothelium).13 The addition of DHCB did not increase the number of rolling cells (Fig 2A) or affect rolling velocity (data not shown) on TNF -stimulated endothelium. DHCB treatment did result in a greater propensity of rolling cells to adhere (a 2-fold increase) relative to their untreated neutrophil counterparts (Fig 2B). The rolling of DHCB-treated neutrophils was still entirely selectin-mediated, because pretreatment with EL-246 (Fig 3A) or fucoidan (data not shown) completely blocked any rolling interaction. DHCB-treated neutrophil adhesion was reduced by the 2 -integrin antibody (IB4 ), but a significant degree of CD18-independent adhesion remained (Fig 3B). It should be noted that neither untreated nor DHCB-treated neutrophils interacted with unstimulated endothelium under shear conditions of 2 dyne/cm2.

View larger version (14K):
[in this window]
[in a new window]
| Fig 2.
Addition of DHCB (causes 4 1 expression in the presence of chemotactic stimuli) had no further effect on the number of rolling neutrophils on TNF -treated endothelium (A). Neutrophil adhesion (B) was further increased (doubled) relative to neutrophils not treated with DHCB. ( ) Untreated; ( ) DHCB-treated. *P < .05 relative to treated cells.
|
|

View larger version (13K):
[in this window]
[in a new window]
| Fig 3.
Addition of EL-246 eliminated neutrophil rolling (A) and adhesion (data not shown) of DHCB-treated cells. The addition of IB4 (B) at a concentration that entirely inhibited untreated neutrophil adhesion to TNF -treated endothelium (Fig 1B) was only 60% effective at reducing adhesion of DHCB-treated neutrophils. However, it should be noted that the number of adherent cells was reduced by 30% from untreated cells (Fig 1B) and 60% from DHCB-treated cells (Fig 2B). For (A), ( ) DHCB-treated or ( ) DHCB-treated + EL-246; for (B), ( ) DHCB-treated + IB4 or ( ) untreated + IB4 . *P < .05 relative to DHCB-treated cells. #P < .05 relative to untreated neutrophils + IB4 .
|
|
DHCB-treated neutrophils adhere to cytokine-stimulated endothelium via the integrin, 4 1 .
Figure 4 shows that the 2 -integrin-independent adhesion of DHCB-pretreated neutrophils was abrogated if, in addition to IB4 , the neutrophils were pretreated with antibodies that inhibit the 4 portion of the 4 1 integrin (HP2/1 or HP1/2). To determine whether the 1 subunit of 4 1 -integrin was involved, we pretreated some cells with an inhibitory antibody that binds 1 -integrin (K20).13,18 This antibody was as effective as the 4 -integrin antibodies in preventing DHCB-treated neutrophil adhesion to TNF -stimulated HUVEC. A second anti- 1 -integrin antibody (LIA1/2) also elicited identical inhibitory results. An isotype control antibody had no effect on the number of adherent cells. Addition of the anti- 4 antibody, HP2/1, by itself (in the absence of an anti- 2 -integrin antibody) did not inhibit 4 1 -expressing neutrophil adhesion to TNF -stimulated endothelium (DHCB-treated [430.8 ± 68.8]; DHCB-treated + HP2/1 [400.6 ± 53.7]; 5-minute values).

View larger version (33K):
[in this window]
[in a new window]
| Fig 4.
Addition of the anti- 4 -integrin antibodies HP2/1 or HP1/2 inhibited the remaining firm adhesion in the presence of IB4. Similar results were seen with the addition of the anti- 1 antibodies K20 or LIA1/2. A control antibody was not inhibitory. *P < .05 relative to DHCB-treated neutrophils + IB4 .
|
|
Table 1 summarizes the rolling data for 4 1 -expressing neutrophils. Each of the antibodies directed against either the 4 or 1 subunit did not decrease the number of rolling neutrophils. In fact, the inhibition of adhesion with 4 - or 1 -integrin antibodies resulted in increased numbers of rolling neutrophils, an observation previously reported for monocytes.12 Addition of the anti- 4 antibody, HP2/1, by itself (in the absence of an anti- 2 -integrin antibody) did not effect neutrophil rolling. As shown in Fig 3A, selectins mediated all of the tethering, rolling, and, as a result, subsequent adhesion at 2 dyne/cm2. When shear was reduced by 0.5 dyne/cm2 at 2-minute intervals in the presence of EL-246, DHCB-treated neutrophils were observed to tether and immediately adhere to the endothelium (Fig 5), with adhesion increasing as shear was decreased. This interaction was inhibited by anti- 4 antibody (HP2/1).

View larger version (16K):
[in this window]
[in a new window]
| Fig 5.
In the presence of antiselectin antibody (EL-246), DHCB-treated neutrophils did not roll or adhere to TNF -treated endothelium at 2 dyne/cm2. Shear was decreased at 2-minute intervals and neutrophil tethering and adhesion was examined in the ( ) presence and ( ) absence of the anti- 4 -integrin antibody, HP2/1. It should be noted that rolling was not observed in this series of experiments. *P < .05 relative to the no antibody condition.
|
|
4 1 -expressing neutrophils can tether to VCAM-1.
For experiments on L cells expressing either VCAM-1 or ICAM-1, neutrophils were stimulated with DHCB and a chemoattractant (FMLP), a combination known to directly induce 4 1 expression.13 FMLP + DHCB-stimulated neutrophils express the 4 - and 1 -subunit but do not express L-selectin. These data have previously been published and are not presented herein. Nevertheless, this observation was reproduced on a number of the days when the flow chamber assays were performed.
When these neutrophils were perfused at wall shear stress of 2 dyne/cm2, they did not interact with monolayers of VCAM-1-transfected L cells, consistent with the importance of selectins in the initial adhesive interaction (Fig 3A). When the shear stress was decreased by decrements of 0.5 dyne/cm2 at 2-minute intervals, 4 1 -expressing neutrophils began to adhere at a shear stress of 1.5 dyne/cm2, with adherence increasing as the shear stress was decreased (Fig 6A). Unstimulated neutrophils or neutrophils stimulated with either FMLP alone or DHCB alone expressed no 4 -integrin and, expectedly, did not roll on or adhere to VCAM-1 transfectants at any shear stress (data not shown). Ramos cells behaved similarly to the 4 1 -expressing neutrophils; Ramos cells also did not adhere at 2 dyne/cm2, but adhered to monolayers of VCAM-1 transfectants at shears of 1.0 dyne/cm2 or less (Fig 6A). Interestingly, 4 1 -expressing neutrophils did not exhibit significant rolling behavior (Fig 6B) on VCAM-1 but rather tethered to the monolayer and adhered immediately at that position. In contrast to 4 1 -expressing neutrophils, Ramos cells exhibited significant rolling behavior (Fig 6B). However, when Ramos cells were activated with PMA, an agent shown to upregulate 4 1 adhesivity,11 they also tethered and immediately adhered (52 ± 9.6 Ramos cells adherent at 5 minutes).

View larger version (14K):
[in this window]
[in a new window]
| Fig 6.
To induce 4 1 expression on neutrophils, the cells were treated with DHCB and an exogenous chemotactic factor, FMLP. Perfusion of ( ) these cells or ( ) Ramos cells over VCAM-1-transfected L cells showed no interactions at 2 dyne/cm2. Reducing shear to less than 2 dyne/cm2 at 2-minute intervals caused neutrophils to tether to VCAM-1 transfectants (A) with very limited rolling (B). Untreated Ramos cells (known to express 4 1 ) interacted with VCAM-1 transfectants at very similar shears as the neutrophils but displayed primarily rolling (B), not adhesion (A).
|
|
The interaction of 4 1 -expressing neutrophils with VCAM-1 could have occurred in a nonspecific fashion in light of the fact that FMLP + DHCB is known to maximally activate neutrophils, resulting in increased avidity and expression of CD18. However, when 4 1 -expressing neutrophils were perfused over monolayers of ICAM-1-transfected L cells (ligand for CD18) under conditions of decreasing shear, tethering interactions did not occur until shear stress was reduced to 0.5 dyne/cm2, at which point minimal tethering interactions were observed (Fig 7A). Thus, 4 1 -expressing neutrophils adhered preferentially to VCAM-1 when compared directly with the ICAM-1 substratum. This interaction was 4 1 -integrin-dependent because HP2/1 blocked adhesion of 4 1 -expressing neutrophils to VCAM-1 transfectants at various shear forces (Fig 7B). In this series of experiments, it was not necessary to add an anti-CD18 antibody, suggesting that CD18 could not tether to VCAM-1 or other surface molecules on L cells. Therefore, the neutrophil tethering and adhesion was entirely dependent on 4 1 -integrin and independent of the 2 -integrin. HP2/1 also blocked Ramos cell interactions with VCAM-1 transfectants (data not shown). Similar results were seen for the anti- 1 antibody LIA1/2 for both cell types (data not shown). Thus, 4 1 expressed on neutrophils can be used by these cells to tether and adhere under lower shear conditions, an event that is not generalizable to all integrins in vitro.

View larger version (14K):
[in this window]
[in a new window]
| Fig 7.
4 1 -expressing neutrophils tethered to VCAM-1-transfected L cells at shears of 1.5, 1.0, and 0.5 dyne/cm2, whereas these same cells did not interact with ICAM-1-transfected L cells until very low shear stresses (A). There were approximately the same number of ICAM-1 and VCAM-1 adhesion molecules per cell (data not shown). When used alone, anti- 4 antibody (HP2/1) blocked neutrophil adhesion to VCAM-1 (B). For (A), ( ) VCAM-1 transfectants or ( ) ICAM-1 transfectants; for (B), ( ) without HP2/1 or ( ) with HP2/1. *P < .05 relative to ICAM-1 value. #P < .05 relative to neutrophils + HP2/1.
|
|
To determine whether the neutrophils adherent to VCAM-1 transfectants could be detached, 4 1 -expressing neutrophils were allowed to settle on VCAM-1 transfectants for 2 minutes, after which flow through the chamber was reestablished to 2 dyne/cm2. Stimulated neutrophils were observed to remain adherent to the VCAM-1 transfectants under shear, an event that was not inhibited by anti-CD18 antibody (IB4 ) but was significantly inhibited by further addition of anti- 1 antibody (K20) or anti- 4 antibody (HP2/1; Fig 8A). Unstimulated Ramos cells also interacted with VCAM-1 transfectants and, upon reintroduction of flow (2 dyne/cm2 ), some cells detached, but the majority of the cells rolled along the VCAM-1 transfectants. The same concentrations of K20 or HP2/1 also inhibited Ramos cell rolling on VCAM-1 transfectants when flow conditions were reestablished (Fig 8B).

View larger version (23K):
[in this window]
[in a new window]
| Fig 8.
4 1 -expressing neutrophils were allowed to settle onto VCAM-1-transfected L cells and flow was initiated to 2 dyne/cm2. This force did not displace the neutrophils in the presence or absence of the anti-CD18 antibody, IB4 (A). Pretreatment of neutrophils with either the anti- 1 antibody (K20) or the anti- 4 integrin antibody (HP2/1) significantly reduced the number of adhering cells (A). These concentrations of HP2/1 or K20 were sufficient to displace Ramos cells from the VCAM-1-transfected L cells (B). For (A), ( ) fMLP + DHCB, ( ) fMLP + DHCB + IB4 , ( ) fMLP + DHCB + IB4 + K20, or ( ) fMLP + DHCB + IB4 + HP2/1. For (B), ( ) no antibody, ( ) K20, or ( ) HP2/1. *P < .05 relative to FMLP + DHCB value. #P < .05 relative to the no antibody condition.
|
|
Neutrophils adhere to fibronectin under static but not flow conditions.
Fibronectin is also a ligand for 4 1 . When 4 1 -expressing neutrophils were perfused over glass coverslips that were coated with human fibronectin, no interactions were observed between shears of 0.5 and 2.0 dyne/cm2. However, 4 1 -expressing neutrophils adhered to fibronectin in a static assay system. Moreover, the adhesion was almost entirely a CD18-independent mechanism (Fig 9). However, the adhesion could be attenuated by the addition of anti-CD18 antibody (IB4 ) in combination with human fibronectin fragment 40K (FN40) or the anti- 4 antibody (HP2/1). FN40 competes with 4 1 -integrin for the fibronectin binding region (CS-1).17

View larger version (27K):
[in this window]
[in a new window]
| Fig 9.
Under static conditions, fibronectin served as ligand for 4 -integrin. Neutrophils adhered avidly to fibronectin and this interaction was not reduced with pretreatment of neutrophils with the anti-CD18 antibody, IB4 . Addition of a fibronectin fragment (FN-40) that contains the CS-1 binding motif for VLA-4 or HP2/1 (anti- 4 -integrin antibody) significantly reduced the adhesive interaction. Under flow conditions, neutrophils were unable to tether to fibronectin (data not shown). ( ) FMLP + DHCB + IB4 ; ( ) FMLP + DHCB + IB4 + FN40; ( ) FMLP + DHCB + IB4 + HP2/1. *P < .05 relative to FMLP + DHCB + IB4 value.
|
|
 |
DISCUSSION |
Until recently, it was generally accepted that 4 1 -integrin was restricted to leukocytes other than neutrophils (the latter use 2 -integrin), and so the potential role of 4 1 -integrin as a recruiter of neutrophils has not been addressed. However, there is a growing body of evidence to suggest that neutrophils can infiltrate numerous tissues independent of 2 -integrin.19-22 Moreover, certain stimuli in vitro can induce the expression of 4 1 -integrin on the surface of human neutrophils13 and, at least in adjuvant-induced arthritic rats, circulating neutrophils express some 4 1 -integrin.14 Based on these findings and the view that 4 1 -integrin has a multifaceted capacity to support tethering, rolling, and adhesion, in this study we investigated the possibility that neutrophils could be recruited to the surface of endothelium independent of the conventional selectin and 2 -integrin pathway.
Our results show that activated endothelium (TNF for 4 hours) could recruit DHCB-treated neutrophils via the 4 1 -integrin pathway even if an anti- 2 -integrin antibody was present. However, neutrophils treated with antibodies against 1 or 4 could not block neutrophil adhesion unless 2 -integrin was simultaneously immunoneutralized. Clearly, the 1 - and 2 -integrin can work in unison or independently to recruit neutrophils to endothelial surfaces. Interestingly, the antibodies directed against either 1 or 4 that prevented neutrophil adhesion did not reduce neutrophil rolling. That particular interaction was dependent on selectins inasmuch as addition of an E/L-selectin antibody or a selectin binding carbohydrate prevented the rolling and the associated adhesion. These data clearly differ from the results with T cells11 and eosinophils,23 which have been reported to roll via 4 1 in vitro. Additionally, we have observed a population of leukocytes that roll via 4 -integrin in chronically inflamed microvessels in vivo.24 The role of 4 1 on neutrophils is reminiscent of the 4 1 -integrin on monocytes, wherein the cells adhered firmly but did not roll via this integrin.12 The differential roles for 4 on different cell types may reflect differences in number and/or avidity of the 4 -integrin.
The role of 4 1 -integrin on neutrophils was further elucidated by perfusing these cells over a single adhesion molecule (VCAM-1). Under the shear conditions (2 dyne/cm2 ) used for endothelium, the neutrophils were not able to interact with the VCAM-1, an observation previously reported for monocytes,12 T cells, and a K562 erythroleukemia cell line transfected with 4 1 .11 However, even a subtle reduction in shear to 1.5 dyne/cm2 was sufficient to permit neutrophil interactions with the VCAM-1-transfected L cells. This interaction was different from the endothelial cell interactions in that the 4 1 -expressing neutrophils tethered and immediately adhered to the VCAM-1 transfectants with essentially no discernible rolling. The difference may be related to the fact that high concentrations of FMLP in the presence of DHCB may maximally activate 4 1 , which translates into immediate adhesion after the tethering interaction. There is a precedent for this behavior; when the avidity of 4 1 on T cells11 or, in this study, on Ramos cells was increased with PMA, these cells also tethered and stably adhered without notable rolling.
This is the first study to demonstrate a role for a 2 -integrin-independent, 4 1 -integrin-dependent mechanism of neutrophil recruitment under shear conditions in the human system. There is a growing body of evidence to invoke a 2 -integrin-independent pathway by which neutrophils can infiltrate inflamed tissues in animal models. Doerschuk et al19 showed that an antibody directed against CD18 entirely inhibited PMA-induced neutrophil movement out of the pulmonary microcirculation; however, the same antibody had no effect on neutrophil emigration associated with Streptococcus pneumoniae or hydrochloric acid. Moreover, a CD18-independent neutrophil infiltration to delayed-type hypersensitivity reactions in joints was also reported.20 Although the role of 4 1 -integrin was not examined in either of these studies, other investigations have shown that antibodies directed against 4 -integrin partly decreased accumulation of neutrophils into skin in a contact hypersensitivity model.25 Because neutrophils were thought not to express 4 -integrin, the investigators suggested that the neutrophil infiltration was dependent in part on 4 -integrin expressing cells that were responsible for recruiting the neutrophils. However, an alternative explanation may be that, following certain inflammatory conditions, the expression and/or activation of 4 -integrin on the surface of neutrophils may contribute to neutrophil recruitment. The data in the present study support this view; human neutrophils can be induced to express 4 1 -integrin and use this adhesion pathway to interact effectively with endothelium even in flow conditions. Interestingly, circulating neutrophils from rats with adjuvant arthritis were positive for the 4 -integrin,14 suggesting that, under at least certain specific inflammatory conditions, this adhesion molecule may be upregulated and may underlie the CD18-independent mechanism of neutrophil infiltration.
In this study, DHCB was used in concert with either endogenous or exogenous chemotactic stimuli to maximally activate neutrophils. It is conceivable that, in systemic inflammatory conditions associated with bacteremia, sepsis, and/or multiple organ failure, accumulation of numerous inflammatory mediators could function like DHCB as a maximal stimulus to induce 4 1 -integrin expression on neutrophils, thereby activating a secondary pathway for neutrophil infiltration. Although increased circulating levels of inflammatory mediators may shed L-selectin and selectin ligands from the surface of neutrophils, because 4 1 -integrin on neutrophils can tether to VCAM-1 at a higher shear than CD18 does to ICAM-1, this may become an important alternative pathway for the recruitment of 4 1 -expressing circulating neutrophils under shear conditions. This was further supported by the observation that 4 1 -expressing neutrophils treated with antiselectin therapy could tether to activated endothelium although shear forces had to be reduced. Although 4 1 -integrin was less efficient at tethering to endothelium and VCAM-1 transfectants than are the selectins, in inflammatory disorders such as ischemia/reperfusion 50% reductions in shear forces are often observed.26 Moreover, in liver and lung, in which neutrophils adhere to the endothelium of sinusoids and capillaries, respectively, the shear forces are greatly reduced and 4 1 -integrin may also be sufficient to support tethering and adhesion.
Although in this study we used a nonphysiologic or artificial stimulus (DHCB) to induce the 4 -integrin-dependent interaction, there are some data to argue that this event may occur in the human system independently of DHCB. First, transmigration of neutrophils across endothelial monolayers in response to chemotactic agents (no DHCB) is sufficient to induce 4 1 -integrin expression.13 This experiment suggests that as yet unidentified physiologic stimuli can indeed induce 4 -integrin expression. Secondarily, Bohnsack et al27 showed that neutrophils lacking 2 -integrin could still adhere to laminin via 1 -integrin. It is presently unclear how DHCB functions to induce the expression of 4 1 -integrin; however, some possibilities presently being investigated include a priming function, a maximal stimulus as might occur with a cocktail of proinflammatory molecules, or simply to maintain the 4 -integrin on the surface of neutrophils, which might rapidly be reinternalized in the absence of appropriate ligands. Indeed, there is evidence that removal of DHCB rapidly reversed the CD18-independent component (unpublished observations).
It remains to be seen whether the CD18-independent component of neutrophil adhesion could mediate significant neutrophil recruitment in vivo. In this study, over the first 5 minutes, the CD18-independent component accounted for approximately 30% to 40% of maximal neutrophil adhesion. It is possible that, over time, the number of cells adhering would reach a plateau that could be similar in magnitude but delayed for CD18-independent adhesion. Indeed, CD18-deficient mice appear to have no impairment in neutrophil recruitment into the inflamed peritoneum at a 24-hour time point, suggesting an efficient CD18-independent mechanism of neutrophil recruitment (Dr C.M. Doerschuk, personal communication, December 1996). Experiments were performed for only 5 minutes because there was no effect of DHCB on the endothelium during that time. Longer periods of time resulted in some endothelial retraction and exposure to substratum (fibronectin) could cause difficulty in interpretation (despite the inability of fibronectin to support adhesion under flow). Nevertheless, over the first 5 minutes, our results clearly show a role for the 4 1 -integrin on neutrophil recruitment under shear conditions and raise the possibility that this mechanism may underlie the CD18-independent recruitment of neutrophils previously described in vivo.
 |
FOOTNOTES |
Submitted September 25, 1996;
accepted January 7, 1997.
Supported by a grant from the Canadian Medical Research Council (MRC). P.K. is an AHFMR and MRC scholar. P.H.R. is funded by an MRC studentship.
Address reprint requests to Paul Kubes, Immunology Research Group, Department of Medical Physiology, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1 Canada.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
 |
REFERENCES |
1.
Fantone JC,
Ward PA:
Polymorphonuclear leukocyte-mediated cell and tissue injury: Oxygen metabolites and their relations to human disease.
Hum Pathol
16:973,
1985[Medline]
[Order article via Infotrieve]
2.
Ley K,
Tedder TF,
Kansas GS:
L-selectin can mediate leukocyte rolling in untreated mesenteric venules in vivo independent of E- or P-selectin.
Blood
82:1632,
1993[Abstract/Free Full Text]
3. Von Andrian UH, Hansell P, Chambers JD, Berger EM, Filho IT, Butcher EC, Arfors KE: L-selectin function is required for 2 -integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol 263:H1034, 1992
4.
Moore KL,
Patel KD,
Brehl RE,
Johnson DA,
Lichenstein HS,
Cummings RD,
Bainton DF,
McEver RP:
P-selectin glycoprotein ligand mediates rolling of human neutrophils on P-selectin.
J Cell Biol
128:661,
1995[Abstract/Free Full Text]
5.
Jones DA,
Abbassi O,
McIntire LV,
McEver RP,
Smith CW:
P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells.
Biophys J
65:1560,
1993[Medline]
[Order article via Infotrieve]
6.
Kubes P,
Kanwar S:
Histamine induces leukocyte rolling in post-capillary venules: A P-selectin-mediated event.
J Immunol
152:3570,
1994[Abstract]
7.
Dore M,
Korthuis RJ,
Granger DN,
Entman ML,
Smith CW:
P-selectin mediates spontaneous leukocyte rolling in vivo.
Blood
82:1308,
1993[Abstract/Free Full Text]
8.
Kanwar S,
Woodman RC,
Poon M-C,
Murohara T,
Lefer AM,
Davenpeck KL,
Kubes P:
Desmopressin induces endothelial P-selectin expression and leukocyte rolling in post-capillary venules.
Blood
86:2760,
1995[Abstract/Free Full Text]
9.
Abbassi O,
Kishimoto TK,
McIntire LV,
Anderson DC,
Smith CW:
E-selectin supports neutrophil rolling in vitro under conditions of flow.
J Clin Invest
92:2719,
1993
10. Kishimoto TK, Anderson DC: The role of integrins in inflammation, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1992, p 353
11.
Alon R,
Kassner PD,
Carr MW,
Finger EB,
Hemler ME,
Springer TA:
The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.
J Cell Biol
128:1243,
1995[Abstract/Free Full Text]
12.
Luscinskas FW,
Ding H,
Tan P,
Cumming D,
Tedder TF,
Gerritsen ME:
L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF- -activated vascular endothelium under flow in vitro.
J Immunol
156:326,
1996
13.
Kubes P,
Niu X-F,
Smith CW,
Kehrli ME Jr,
Reinhardt PH,
Woodman RC:
A novel 1 -dependent adhesion pathway on neutrophils: A mechanism invoked by dihydrocytochalasin B or endothelial transmigration.
FASEB J
9:1103,
1995[Abstract]
14.
Issekutz TB,
Miyasaka M,
Issekutz AC:
Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation.
J Exp Med
183:2175,
1996[Abstract/Free Full Text]
15.
Vonderheide RH,
Tedder TF,
Springer TA,
Staunton DE:
Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4.
J Cell Biol
125:215,
1994[Abstract/Free Full Text]
16.
Lawrence MB,
Springer TA:
Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins.
Cell
65:859,
1991[Medline]
[Order article via Infotrieve]
17.
Wayner EA,
Garcia-Pardo A,
Humphries MJ,
McDonald JA,
Carter WG:
Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.
J Cell Biol
109:1321,
1989[Abstract/Free Full Text]
18.
Poul MA,
Ticchioni M,
Bernard A,
Lefranc MP:
Inhibition of T-cell activation with a humanized anti-beta1 integrin chain mAb.
Mol Immunol
32:101,
1995[Medline]
[Order article via Infotrieve]
19.
Doerschuk CM,
Winn RK,
Coxson HO,
Harlan JM:
CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits.
J Immunol
144:2327,
1990[Abstract]
20.
Issekutz AC,
Issekutz TB:
A major portion of polymorphonuclear leukocyte and T lymphocyte migration to arthritic joints in the rat is via LFA-1/MAC-1-independent mechanisms.
Clin Immunol Immunopathol
67:257,
1993[Medline]
[Order article via Infotrieve]
21.
Winn RK,
Harlan JM:
CD18-independent neutrophil and mononuclear leukocyte emigration into the peritoneum of rabbits.
J Clin Invest
92:1168,
1993
22.
Arndt H,
Kubes P,
Grisham MB,
Gonzalez E,
Granger DN:
Granulocyte turnover in the feline intestine.
Inflammation
16:549,
1992[Medline]
[Order article via Infotrieve]
23.
Sriramarao P,
Von Andrian UH,
Butcher EC,
Bourdon MA,
Broide DH:
L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo.
J Immunol
153:4238,
1994[Abstract]
24.
Johnston B,
Issekutz TB,
Kubes P:
The 4 -integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo.
J Exp Med
181:1,
1996[Free Full Text]
25.
Chishom PL,
Williams CA,
Lobb RR:
Monoclonal antibodies to the integrin alpha-4 subunit inhibit the murine contact hypersensitivity response.
Eur J Immunol
23:682,
1996
26.
Kubes P,
Jutila M,
Payne D:
Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion.
J Clin Invest
95:2510,
1995
27.
Bohnsack JF,
Akiyama SK,
Damsky CH,
Knape WA,
Zimmerman GA:
Human neutrophil adherence to laminin in vitro.
J Exp Med
171:1221,
1990[Abstract/Free Full Text]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. P. Kuligowski, R. Y. Q. Kwan, C. Lo, C. Wong, W. G. James, D. Bourges, J. D. Ooi, L. D. Abeynaike, P. Hall, A. R. Kitching, et al.
Antimyeloperoxidase antibodies rapidly induce {alpha}4-integrin-dependent glomerular neutrophil adhesion
Blood,
June 18, 2009;
113(25):
6485 - 6494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Petty, C. C. Lenox, D. J. Weiss, M. E. Poynter, and B. T. Suratt
Crosstalk between CXCR4/Stromal Derived Factor-1 and VLA-4/VCAM-1 Pathways Regulates Neutrophil Retention in the Bone Marrow
J. Immunol.,
January 1, 2009;
182(1):
604 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Heit, L. Liu, P. Colarusso, K. D. Puri, and P. Kubes
PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP
J. Cell Sci.,
January 15, 2008;
121(2):
205 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou, B. M. Lapointe, S. R. Clark, L. Zbytnuik, and P. Kubes
A Requirement for Microglial TLR4 in Leukocyte Recruitment into Brain in Response to Lipopolysaccharide
J. Immunol.,
December 1, 2006;
177(11):
8103 - 8110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Bonder, S. R. Clark, M. U. Norman, P. Johnson, and P. Kubes
Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere
Blood,
June 15, 2006;
107(12):
4798 - 4806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Woo, J.-H. Lim, and J.-H. Kim
VCAM-1 upregulation via PKC{delta}-p38 kinase-linked cascade mediates the TNF-{alpha}-induced leukocyte adhesion and emigration in the lung airway epithelium
Am J Physiol Lung Cell Mol Physiol,
February 1, 2005;
288(2):
L307 - L316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Speyer, H. Gao, N. J. Rancilio, T. A. Neff, G. B. Huffnagle, J. V. Sarma, and P. A. Ward
Novel Chemokine Responsiveness and Mobilization of Neutrophils during Sepsis
Am. J. Pathol.,
December 1, 2004;
165(6):
2187 - 2196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alvarez, M. Cerda-Nicolas, Y. Naim Abu Nabah, M. Mata, A. C. Issekutz, J. Panes, R. R. Lobb, and M.-J. Sanz
Direct evidence of leukocyte adhesion in arterioles by angiotensin II
Blood,
July 15, 2004;
104(2):
402 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Amersi, X.-D. Shen, C. Moore, J. Melinek, R. W. Busuttil, J. W. Kupiec-Weglinski, and A. J. Coito
Fibronectin-{alpha}4{beta}1 Integrin-Mediated Blockade Protects Genetically Fat Zucker Rat Livers from Ischemia/Reperfusion Injury
Am. J. Pathol.,
April 1, 2003;
162(4):
1229 - 1239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Wyman, A. J. Bjornsen, D. J. Elzi, C. W. Smith, K. M. England, M. Kelher, and C. C. Silliman
A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release
Am J Physiol Cell Physiol,
December 1, 2002;
283(6):
C1592 - C1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gironella, M. Molla, A. Salas, A. Soriano, M. Sans, D. Closa, P. Engel, A. Salas, J. M. Pique, and J. Panes
The role of P-selectin in experimental colitis as determined by antibody immunoblockade and genetically deficient mice
J. Leukoc. Biol.,
July 1, 2002;
72(1):
56 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tasaka, S. E. Richer, J. P. Mizgerd, and C. M. Doerschuk
Very Late Antigen-4 in CD18-Independent Neutrophil Emigration during Acute Bacterial Pneumonia in Mice
Am. J. Respir. Crit. Care Med.,
July 1, 2002;
166(1):
53 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Pettersen and K. B. Adler
Airways Inflammation and COPD* : Epithelial-Neutrophil Interactions
Chest,
May 1, 2002;
121(5_suppl):
142S - 150S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kaur, R. C. Woodman, L. Ostrovsky, and P. Kubes
Selective recruitment of neutrophils and lymphocytes by thrombin: a role for NF-{kappa}B
Am J Physiol Heart Circ Physiol,
August 1, 2001;
281(2):
H784 - H795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Cotter, K. E. Norman, P. G. Hellewell, and V. C. Ridger
A Novel Method for Isolation of Neutrophils from Murine Blood Using Negative Immunomagnetic Separation
Am. J. Pathol.,
August 1, 2001;
159(2):
473 - 481.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. B. Henderson, L. H.K. Lim, P. A. Tessier, F. N.E. Gavins, M. Mathies, M. Perretti, and N. Hogg
The Use of Lymphocyte Function-associated Antigen (LFA)-1-deficient Mice to Determine the Role of LFA-1, Mac-1, and {alpha}4 Integrin in the Inflammatory Response of Neutrophils
J. Exp. Med.,
July 16, 2001;
194(2):
219 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Burns, T. B. Issekutz, H. Yagita, and A. C. Issekutz
The {{alpha}}4{{beta}}1 (Very Late Antigen (VLA)-4, CD49d/CD29) and {{alpha}}5{{beta}}1 (VLA-5, CD49e/CD29) Integrins Mediate {{beta}}2 (CD11/CD18) Integrin-Independent Neutrophil Recruitment to Endotoxin-Induced Lung Inflammation
J. Immunol.,
April 1, 2001;
166(7):
4644 - 4649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pereira, M. Zhou, A. Mocsai, and C. Lowell
Resting Murine Neutrophils Express Functional {{alpha}}4 Integrins that Signal Through Src Family Kinases
J. Immunol.,
March 15, 2001;
166(6):
4115 - 4123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Ridger, B. E. Wagner, W. A. H. Wallace, and P. G. Hellewell
Differential Effects of CD18, CD29, and CD49 Integrin Subunit Inhibition on Neutrophil Migration in Pulmonary Inflammation
J. Immunol.,
March 1, 2001;
166(5):
3484 - 3490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Briaud, Z.-M. Ding, L. H. Michael, M. L. Entman, S. Daniel, and C. M. Ballantyne
Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice
Am J Physiol Heart Circ Physiol,
January 1, 2001;
280(1):
H60 - H67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y. Larbi, A. R. Allen, F. W. K. Tam, D. O. Haskard, R. R. Lobb, P. M. R. Silva, and S. Nourshargh
VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration
Blood,
November 15, 2000;
96(10):
3601 - 3609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Wagner and R. A. Roth
Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature
Pharmacol. Rev.,
September 1, 2000;
52(3):
349 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kirveskari, P. Bono, K. Granfors, M. Leirisalo-Repo, S. Jalkanen, and M. Salmi
Expression of {alpha}4-integrins on human neutrophils
J. Leukoc. Biol.,
August 1, 2000;
68(2):
243 - 250.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. E. May, F.-J. Neumann, A. Schomig, and K. T. Preissner
VLA-4 (alpha 4beta 1) engagement defines a novel activation pathway for beta 2 integrin-dependent leukocyte adhesion involving the urokinase receptor
Blood,
July 15, 2000;
96(2):
506 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ali, J. Kaur, and K. D. Patel
Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Regulated on Activation Normal T Cell Expressed and Secreted Are Expressed by Human Breast Carcinoma Cells and Support Eosinophil Adhesion and Activation
Am. J. Pathol.,
July 1, 2000;
157(1):
313 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ostrovsky, J. Carvalho-Tavares, R. C. Woodman, and P. Kubes
Translational inhibition of E-selectin expression stimulates P-selectin-dependent neutrophil recruitment
Am J Physiol Heart Circ Physiol,
April 1, 2000;
278(4):
H1225 - H1232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Johnston, A. Chee, T. B. Issekutz, T. Ugarova, A. Fox-Robichaud, M. J. Hickey, and P. Kubes
{alpha}4 Integrin-Dependent Leukocyte Recruitment Does Not Require VCAM-1 in a Chronic Model of Inflammation
J. Immunol.,
March 15, 2000;
164(6):
3337 - 3344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Birner, T. B. Issekutz, U. Walter, and A. C. Issekutz
The role of {alpha}4 and LFA-1 integrins in selectin-independent monocyte and neutrophil migration to joints of rats with adjuvant arthritis
Int. Immunol.,
February 1, 2000;
12(2):
141 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ho and N. J. White
Molecular mechanisms of cytoadherence in malaria
Am J Physiol Cell Physiol,
June 1, 1999;
276(6):
C1231 - C1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Walzog, K. Scharffetter-Kochanek, and P. Gaehtgens
Impairment of neutrophil emigration in CD18-null mice
Am J Physiol Gastrointest Liver Physiol,
May 1, 1999;
276(5):
G1125 - G1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Brodie, C. de la Rosa, J. G. Howe, J. Crouch, W. D. Travis, and K. Diem
Pediatric AIDS-Associated Lymphocytic Interstitial Pneumonia and Pulmonary Arterio-Occlusive Disease : Role of VCAM-1/VLA-4 Adhesion Pathway and Human Herpesviruses
Am. J. Pathol.,
May 1, 1999;
154(5):
1453 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Catalina, P. Estess, and M. H. Siegelman
Selective Requirements for Leukocyte Adhesion Molecules in Models of Acute and Chronic Cutaneous Inflammation: Participation of E- and P- But Not L-Selectin
Blood,
January 15, 1999;
93(2):
580 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Reinhardt and P. Kubes
Differential Leukocyte Recruitment From Whole Blood Via Endothelial Adhesion Molecules Under Shear Conditions
Blood,
December 15, 1998;
92(12):
4691 - 4699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamamoto, O. Kajikawa, T. R. Martin, S. R. Sharar, J. M. Harlan, and R. K. Winn2
The Role of Leukocyte Emigration and IL-8 on the Development of Lipopolysaccharide-Induced Lung Injury in Rabbits
J. Immunol.,
November 15, 1998;
161(10):
5704 - 5709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Patel
Eosinophil Tethering to Interleukin-4-Activated Endothelial Cells Requires Both P-Selectin and Vascular Cell Adhesion Molecule-1
Blood,
November 15, 1998;
92(10):
3904 - 3911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scalia, J. Z. Appel III, and A. M. Lefer
Leukocyte-Endothelium Interaction During the Early Stages of Hypercholesterolemia in the Rabbit : Role of P-Selectin, ICAM-1, and VCAM-1
Arterioscler. Thromb. Vasc. Biol.,
July 1, 1998;
18(7):
1093 - 1100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Davenpeck, S. A. Sterbinsky, and B. S. Bochner
Rat Neutrophils Express alpha 4 and beta 1 Integrins and Bind to Vascular Cell Adhesion Molecule-1 (VCAM-1) and Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1)
Blood,
April 1, 1998;
91(7):
2341 - 2346.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|